BIOAVAILABILITY AND PHARMACOKINETICS OF PREDNISONE IN HUMANS = BIODISPONIBILITE ET PHARMACOCINETIQUE DE LA PREDNISONE CHEZ L'HOMMEDISANTO AR; DESANTE KA.1975; J. PHARM. SCI.; U.S.A.; DA. 1975; VOL. 64; NO 1; PP. 109-112; BIBL. 11REF.Article

EFFECT OF PROBENECID ON THE PHARMACOKINETICS OF MOXALACTAMDESANTE KA; ISRAEL KS; BRIER GL et al.1982; ANTIMICROB. AGENTS CHEMOTHER.; ISSN 0066-4804; USA; DA. 1982; VOL. 21; NO 1; PP. 58-61; BIBL. 26 REF.Article

PHARMACOKINETIC INTERPRETATION OF PLASMA CORTISOL AND CORTISONE CONCENTRATIONS FOLLOWING A SINGLE ORAL ADMINISTRATION OF CORTISONE ACETATE TO HUMAN SUBJECTSCOLBURN WA; DISANTO AR; STUBBS SS et al.1980; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1980; VOL. 20; NO 7; PP. 428-436; BIBL. 17 REF.Article

GENERIC PROPOXYPHENE: NEED FOR CLINICAL BIOAVAILABILITY EVALUATION.DESANTE KA; STOLL RG; KAISER DG et al.1977; J. PHARM. SCI.; U.S.A.; DA. 1977; VOL. 66; NO 12; PP. 1713-1716; BIBL. 11 REF.Article

BENOXAPROFEN KINETICS IN RENAL IMPAIRMENTARONOFF GR; OZAWA T; DESANTE KA et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 2; PP. 190-194; BIBL. 11 REF.Article

CLINICAL BIOAVAILABILITY OF NITROFURANTOIN. A CASE OF BIOINEQUIVALENCEDISANTO AR; CHODOS DJ; PHILLIPS JP et al.1976; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; GERM.; DA. 1976; VOL. 13; NO 3; PP. 220-227; BIBL. 9 REF.Article

LINCOMYCIN SERUM AND SALIVA CONCENTRATIONS AFTER INTRAMUSCULAR INJECTION OF HIGH DOSESSMITH RB; LUMMIS WL; MONOVICH RE et al.1981; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1981; VOL. 21; NO 10; PP. 411-417; BIBL. 15 REF.Article

INFLUENCE OF SULFAETHIDOLE ON THE HUMAN PHARMACOKINETICS OF DICLOXACILLINDESANTE KA; DITTERT LW; STAVCHANSKY S et al.1980; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1980; VOL. 20; NO 8-9; PP. 534-542; BIBL. 17 REF.Article

PHARMOKINETIC EVALUATION OF A DRUG INTERACTION BETWEEN KAOLIN-PECTIN AND CLINDAMYCINALBERT KS; DESANTE KA; WELCH RD et al.1978; J. PHARM. SCI.; USA; DA. 1978; VOL. 67; NO 11; PP. 1579-1582; BIBL. 13 REF.Article

CHLORPHENESIN CARBAMATE SERUM LEVELS DURING SUBCHRONIC ADMINISTRATION TO HUMAN (NORMAL) VOLUNTEERSSTOLL RG; DESANTE KA; NOVAK E et al.1974; J. CLIN. PHARMACOL.; U.S.A.; DA. 1974; VOL. 14; NO 10; PP. 520-524; BIBL. 5 REF.Article

DOUBLE LATIN SQUARE STUDY TO DETERMINE VARIABILITY AND RELATIVE BIOAVAILABILITY OF METHYLPREDNISOLONEALBERT KS; BROWN SW JR; DESANTE KA et al.1979; J. PHARM. SCI.; USA; DA. 1979; VOL. 68; NO 10; PP. 1312-1316; BIBL. 7 REF.Article

COMPARATIVE BIOAVAILABILITY EVALUATION OF ERYTHROMYCIN BASE AND ITS SALTS AND ESTERS. I: ERYTHROMYCIN ESTOLATE CAPSULES VERSUS ENTERIC-COATED ERYTHROMYCIN BASE TABLETSDISANTO AR; TSERNG KY; CHODOS DJ et al.1980; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1980; VOL. 20; NO 7; PP. 437-443; BIBL. 21 REF.Article

INFLUENCE OF KAOLIN. PECTIN SUSPENSION ON DIGOXIN BIOAVAILABILITY.ALBERT KS; AYRES JW; DISANTO AR et al.1978; J. PHARM. SCI.; USA; DA. 1978; VOL. 67; NO 11; PP. 1582-1586; BIBL. 4 REF.Article